Impact of Co-existing Paroxysmal Atrial Fibrillation on Different Outcomes of Hospitalized COVID-19 Patients: Nationwide Inpatient Sample Analysis (2020) With Propensity Score Matching.

[1]  Chi-Yen Wang,et al.  Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks , 2022, eClinicalMedicine.

[2]  M. Link,et al.  New-Onset Atrial Fibrillation in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Registry , 2022, Circulation. Arrhythmia and electrophysiology.

[3]  Meng Liu,et al.  Outcomes of atrial fibrillation in patients with COVID-19 pneumonia: A systematic review and meta-analysis , 2021, The American Journal of Emergency Medicine.

[4]  Y. Kawaoka,et al.  Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition , 2021, bioRxiv.

[5]  C. Specchia,et al.  Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study , 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[6]  G. Lip,et al.  Prevalence and Impact of Atrial Fibrillation in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis , 2021, Journal of clinical medicine.

[7]  M. Zuin,et al.  Pre-existing atrial fibrillation is associated with increased mortality in COVID-19 Patients , 2021, Journal of Interventional Cardiac Electrophysiology.

[8]  Roshan Chhetri,et al.  A Literature Review on Impact of COVID-19 Pandemic on Teaching and Learning , 2021, Higher Education for the Future.

[9]  M. Revel,et al.  Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis , 2020, Radiology.

[10]  Y. Hu,et al.  [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[11]  R. Bartenschlager,et al.  Integrative Imaging Reveals SARS-CoV-2-Induced Reshaping of Subcellular Morphologies , 2020, Cell Host & Microbe.

[12]  C. Weber,et al.  Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19 , 2020, Thrombosis and Haemostasis.

[13]  A. Amanullah,et al.  Arrhythmia in COVID-19 , 2020, SN Comprehensive Clinical Medicine.

[14]  S. Nattel,et al.  Atrial Myocyte NLRP3/CaMKII Nexus Forms a Substrate for Postoperative Atrial Fibrillation , 2020, Circulation research.

[15]  K. Bhaskaran,et al.  OpenSAFELY: factors associated with COVID-19 death in 17 million patients , 2020, Nature.

[16]  S. Luo,et al.  Targeting inflammation and cytokine storm in COVID-19 , 2020, Pharmacological Research.

[17]  R. Cianci,et al.  Age and Multimorbidity Predict Death Among COVID-19 Patients , 2020, Hypertension.

[18]  B. Abella,et al.  COVID-19 and cardiac arrhythmias , 2020, Heart Rhythm.

[19]  Yutao Guo,et al.  COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up , 2020, Journal of the American College of Cardiology.

[20]  Abraham J. Koster,et al.  A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis , 2020, bioRxiv.

[21]  C. Boos.  Infection and atrial fibrillation: inflammation begets AF. , 2020, European heart journal.

[22]  F. Mair,et al.  Multimorbidity and the COVID-19 pandemic – An urgent call to action , 2020, Journal of comorbidity.

[23]  G. Lip,et al.  Long-Term Relationship Between Atrial Fibrillation, Multimorbidity and Oral Anticoagulant Drug Use. , 2019, Mayo Clinic proceedings.

[24]  B. Sobkowicz,et al.  Atrial Fibrillation in Patients with Acute Pulmonary Embolism: Clinical Significance and Impact on Prognosis , 2019, BioMed research international.

[25]  G. Tse,et al.  Atrial fibrillation is related to lower incidence of deep venous thrombosis in patients with pulmonary embolism. , 2018, Journal of thoracic disease.

[26]  R. Arena,et al.  Endothelial dysfunction and pathophysiological correlates in atrial fibrillation , 2008, Heart.

[27]  K. Flegel.  When atrial fibrillation occurs with pulmonary embolism, is it the chicken or the egg? , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[28]  L H Kuller,et al.  Incidence of and risk factors for atrial fibrillation in older adults. , 1997, Circulation.